ORION CORPORATION STOCK EXCHANGE RELEASE 8 OCTOBER 2014 at 9:00 a.m. EEST Publishing of Orion Corporation's Interim Report for January-September 2014 on 21 October 2014 Orion will publish its Interim Report January-September 2014 on Tuesday, 21 October 2014 approximately at 12:00 Finnish time (EEST). The release and related presentation material in Finnish and in English will be available on the Group's homepage at www.orion.fi/en/Orion-group/investors promptly after the publishing. News conference for analysts and media on Tuesday 21 October 2014 at 13:30 EEST A news conference for analysts and media will be held on Tuesday 21 October 2014 at 13:30 EEST at Hotel Kämp, address Pohjoisesplanadi 29, Helsinki. President and CEO Timo Lappalainen will give a brief presentation in English on the financial review. Live webcast and conference call The event can be followed live as a webcast accessible at http://qsb.webcast.fi/o/orion/orion_2014_1021_q3 Questions can be asked also through conference call lines after the result presentation. The conference call ID is 948474 and the phone numbers to participate the conference are: when calling from the United States +1 334 323 6203 when calling from other countries +44 (0)20 7162 0125 News conference recordings A recording of the event in English and a recording of the presentation by the President and CEO in Finnish will be available on the Orion website later the same day. Silent period The silent period preceding the publication is ongoing and continues until the disclosure. Orion Corporation Timo Lappalainen Jari Karlson President and CEO CFO Publisher: Orion Corporation www.orion.fi/en Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs. Orion's net sales in 2013 amounted to EUR 1, 007 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki. [HUG#1861438]
Publishing of Orion Corporation's Interim Report for
Top 10 Most Recent News Articles
Thoughts Unleashed Arrives With a Personal American Voice
A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...
Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions
A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....
Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron
A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...
Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices
Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...
Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit
Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....
Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant
A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...
Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights
Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...
Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down
Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...
Continue Reading
Giovanni Recalde Sues County After False Report
Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...
Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability
A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...
Continue ReadingTop 5 Most Recently Viewed Articles
Xanadu Mines Expands Funding to $7.5 Million for Growth
Xanadu Mines Secures Expanded Funding of $7.5 Million Highlights of the Funding Expansion The recent placement undertaken by Xanadu Mines Ltd, increasing its funding to a total of $7.5 million, marks an essential milestone for the company. This expansion adds $2 million to its initial placement announced earlier in November. The additional capital is critical for Xanadu...
Continue Reading
First Advantage: What Investors Should Know About Recent Changes
Recent Developments Regarding First Advantage Corporation First Advantage Corporation (NASDAQ: FA) is experiencing a downturn in share prices following a recent downgrade from Wolfe Research. The company has shifted from an Outperform rating to a Peer Perform rating, raising concerns among investors. The Insights from Wolfe Research Wolfe Research's analysts have...
Continue Reading
Exploring 89bio's Upcoming Fireside Chat at Healthcare Conference
89bio's Participation in Healthcare Conferences 89bio, Inc., a pioneer in developing therapies for liver and cardiometabolic diseases, is gearing up for a significant engagement at an upcoming healthcare conference. About the Conference The Leerink Partners Global Healthcare Conference is an important event where stakeholders from the biopharmaceutical field gather. This...
Continue Reading
Transforming Finance Operations: The Rise of Advanced Solutions
The Evolution of Finance Outsourcing As business operations continue to evolve rapidly, many companies are expanding their finance and accounting outsourcing services. Increasingly, organizations are looking for specialized skills from their service providers. Recent insights reveal a shift in client expectations, pushing providers to offer a broader range of services...
Continue Reading
Understanding Alliance Pharma's Recent Trading Activities
Recent Disclosures from Alliance Pharma plc Alliance Pharma plc, known for its strategic developments in the pharmaceutical sector, has been active in the market, with notable disclosures coming from its exempt principal trader, Investec Bank plc. This recent disclosure falls under the guidelines of Rule 8.5 from the Takeover Code, reflecting a transparent approach to...
Continue Reading